Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01719315 : Neurophysiologic Correlates of Hypersomnia
PhaseN/A
AgesMin: 18 Years Max: 60 Years
Eligibility
Inclusion Criteria:

- Meet Diagnostic and Statistical Manual edition IV criteria for neuropsychiatric
disorders enumerated in study population description

Exclusion Criteria:

Exclusionary criteria for all subjects will include: evidence of a clinically significant
sleep disorder that would cause hypersomnolence (e.g. moderate to severe obstructive sleep
apnea, restless legs syndrome, shift-work sleep disorder), history of significant head
trauma or loss of consciousness > 30 minutes; current smoking of more than 15 cigarettes
per day; >3 caffeinated beverages per day; significant neurologic or medical illness;
active drug/alcohol abuse/dependence (within 6 months of enrollment), women who are
pregnant, <6 months post-partum, nursing or planning to become pregnant during the study;
left-handedness (due to effects on sleep topography); and imminent risk for self-harm or
suicide.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01719315      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740